Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Immunovant, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
6 insiders, $1.12M in total
Insiders trading
6
Net value
−$1.12M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Immunovant, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Immunovant, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Van Tuyl ChristopherChief Legal Officer176,545Sep 25, 20268
Pande AtulDirector116,731Aug 28, 20266
Gloria MelanieChief Operating Officer219,301Aug 21, 20268
Girao TiagoChief Financial Officer240,798Jul 24, 20264
Stout Jay SChief Technology Officer205,341Jul 24, 202610
Venker EricChief Executive Officer254,280Jul 6, 20263
Fromkin Andrew J.Director74,382May 29, 20263
Susman Robert GrahamDirector36,394May 1, 20262
Torti FrankDirector1,009,228Apr 9, 20261
Bauer JakeDirector38,896Apr 9, 20261
Hughes Douglas J.Director134,653Apr 9, 20262
Roivant Sciences Ltd.Director, 10% Owner113,317,007Dec 12, 20251
Geffner MichaelChief Medical Officer217,958Oct 24, 20252
Salzmann PeterChief Executive Officer1,178,191Apr 17, 20250
Barnett Eva ReneeChief Financial Officer396,774Apr 17, 20250
Migausky George VDirector137,251Apr 3, 20250
Macias William L.Chief Medical Officer357,353Feb 21, 20250
Levine Mark S.Chief Legal Officer319,228Nov 22, 20240
Butchko Julia G.Chief Development Officer440,959Aug 23, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 19, 2024 (view filing)Jul 172 daysBarnett Eva ReneeChief Financial OfficerSSale−3.12K$29.69−$92.7K−0.9%347.5K after2 lots
Jul 19, 2024 (view filing)Jul 172 daysMacias William L.Chief Medical OfficerSSale−3.04K$29.69−$90.4K−0.8%371.4K after4 lots
Jul 19, 2024 (view filing)Jul 172 daysLevine Mark S.Chief Legal OfficerSSale−2.50K$29.69−$74.4K−0.7%337.4K after2 lots
Jul 26, 2024 (view filing)Jul 242 daysLevine Mark S.Chief Legal OfficerSSale−4.01K$27.76−$111.5K−1.2%333.4K after
Jul 26, 2024 (view filing)Jul 242 daysGeffner MichaelChief Medical OfficerSSale−3.46K$27.76−$95.9K−2.4%138.2K after
Jul 26, 2024 (view filing)Jul 242 daysStout Jay SChief Technology OfficerSSale−2.81K$27.76−$78.1K−1.9%144.9K after
Aug 23, 2024 (view filing)Aug 212 daysSalzmann PeterChief Executive OfficerSSale−15.1K$31.86−$480.1K−1.5%1.01M after2 lots
Aug 23, 2024 (view filing)Aug 212 daysButchko Julia G.Chief Development OfficerSSale−3.03K$31.86−$96.4K−0.7%441.0K after2 lots
Aug 23, 2024 (view filing)Aug 212 daysBarnett Eva ReneeChief Financial OfficerSSale−3.77K$31.86−$120.0K−1.1%343.8K after2 lots
Aug 23, 2024 (view filing)Aug 212 daysMacias William L.Chief Medical OfficerSSale−3.03K$31.86−$96.4K−0.8%368.3K after2 lots
Aug 23, 2024 (view filing)Aug 212 daysLevine Mark S.Chief Legal OfficerSSale−3.29K$31.86−$105.0K−1.0%330.1K after2 lots
Oct 11, 2024 (view filing)Oct 92 daysSalzmann PeterChief Executive OfficerSSale−4.46K$29.56−$131.8K−0.4%1.00M after
Oct 11, 2024 (view filing)Oct 92 daysBarnett Eva ReneeChief Financial OfficerSSale−5.16K$29.56−$152.6K−1.5%338.6K after
Oct 18, 2024 (view filing)Oct 162 daysBarnett Eva ReneeChief Financial OfficerSSale−3.27K$28.79−$94.2K−1.0%335.3K after
Oct 18, 2024 (view filing)Oct 162 daysLevine Mark S.Chief Legal OfficerSSale−2.86K$28.79−$82.3K−0.9%327.2K after
Oct 18, 2024 (view filing)Oct 162 daysMacias William L.Chief Medical OfficerSSale−3.19K$28.79−$91.8K−0.9%365.1K after2 lots
Oct 18, 2024 (view filing)Oct 162 daysSalzmann PeterChief Executive OfficerSSale−9.10K$28.79−$261.8K−0.9%994.8K after
Oct 25, 2024 (view filing)Oct 232 daysStout Jay SChief Technology OfficerSSale−2.74K$29.53−$80.9K−1.9%142.2K after
Oct 25, 2024 (view filing)Oct 232 daysGeffner MichaelChief Medical OfficerSSale−3.19K$29.53−$94.2K−2.3%135.0K after
Oct 25, 2024 (view filing)Oct 232 daysLevine Mark S.Chief Legal OfficerSSale−4.36K$29.53−$128.8K−1.3%322.9K after
Nov 22, 2024 (view filing)Nov 202 daysSalzmann PeterChief Executive OfficerSSale−16.7K$25.45−$424.8K−1.7%978.1K after
Nov 22, 2024 (view filing)Nov 202 daysBarnett Eva ReneeChief Financial OfficerSSale−4.17K$25.45−$106.2K−1.2%331.2K after
Nov 22, 2024 (view filing)Nov 202 daysMacias William L.Chief Medical OfficerSSale−3.35K$25.45−$85.3K−0.9%361.8K after
Nov 22, 2024 (view filing)Nov 202 daysLevine Mark S.Chief Legal OfficerSSale−3.65K$25.45−$92.9K−1.1%319.2K after
Dec 4, 2024 (view filing)Dec 22 daysHughes Douglas J.DirectorSSale−5.42K$28.54−$154.8K−4.3%119.6K after10b5-1
Dec 4, 2024 (view filing)Dec 22 daysPande AtulDirectorSSale−7.75K$28.54−$221.2K−8.2%86.7K after10b5-1
Jan 10, 2025 (view filing)Jan 82 daysSalzmann PeterChief Executive OfficerSSale−5.11K$24.10−$123.0K−0.5%973.0K after
Jan 10, 2025 (view filing)Jan 82 daysBarnett Eva ReneeChief Financial OfficerSSale−4.11K$24.10−$98.9K−1.2%327.1K after
Jan 15, 2025 (view filing)Jan 132 daysRoivant Sciences Ltd.Director, 10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+16.8M$20.00+$336.9M+21.1%96.7M after
Jan 17, 2025 (view filing)Jan 152 daysSalzmann PeterChief Executive OfficerSSale−8.77K$23.83−$208.9K−0.9%964.2K after2 lots
Jan 17, 2025 (view filing)Jan 152 daysBarnett Eva ReneeChief Financial OfficerSSale−2.30K$23.83−$54.8K−0.7%324.8K after2 lots
Jan 17, 2025 (view filing)Jan 152 daysMacias William L.Chief Medical OfficerSSale−2.38K$23.83−$56.8K−0.7%359.4K after4 lots
Jan 24, 2025 (view filing)Jan 222 daysGeffner MichaelChief Medical OfficerSSale−2.66K$23.59−$62.7K−2.0%132.3K after
Jan 24, 2025 (view filing)Jan 222 daysStout Jay SChief Technology OfficerSSale−2.19K$23.59−$51.8K−1.5%140.0K after
Feb 21, 2025 (view filing)Feb 192 daysSalzmann PeterChief Executive OfficerSSale−15.4K$20.86−$322.1K−1.6%948.8K after
Feb 21, 2025 (view filing)Feb 192 daysBarnett Eva ReneeChief Financial OfficerSSale−2.81K$20.86−$58.7K−0.9%322.0K after
Feb 21, 2025 (view filing)Feb 192 daysMacias William L.Chief Medical OfficerSSale−2.06K$20.86−$42.9K−0.6%357.4K after
Mar 11, 2025 (view filing)Mar 74 daysFromkin Andrew J.DirectorSSale−8.00K$19.60−$156.8K−8.0%91.9K after2 lots10b5-1
Apr 11, 2025 (view filing)Apr 92 daysSalzmann PeterChief Executive OfficerSSale−28.1K$12.99−$364.9K−2.3%1.19M after
Apr 11, 2025 (view filing)Apr 92 daysBarnett Eva ReneeChief Financial OfficerSSale−11.1K$12.99−$143.7K−2.7%399.8K after2 lots
Apr 11, 2025 (view filing)Apr 92 daysGeffner MichaelChief Medical OfficerSSale−6.17K$12.99−$80.1K−2.6%227.7K after
Apr 11, 2025 (view filing)Apr 92 daysStout Jay SChief Technology OfficerSSale−5.00K$12.99−$65.0K−2.3%211.2K after
Apr 17, 2025 (view filing)Apr 161 daySalzmann PeterChief Executive OfficerSSale−8.32K$14.89−$123.9K−0.7%1.18M after
Apr 17, 2025 (view filing)Apr 161 dayBarnett Eva ReneeChief Financial OfficerSSale−2.99K$14.89−$44.6K−0.7%396.8K after
Apr 25, 2025 (view filing)Apr 232 daysGeffner MichaelChief Medical OfficerSSale−2.35K$14.79−$34.7K−1.0%225.4K after
Apr 25, 2025 (view filing)Apr 232 daysStout Jay SChief Technology OfficerSSale−1.93K$14.79−$28.5K−0.9%209.2K after
Jul 11, 2025 (view filing)Jul 92 daysStout Jay SChief Technology OfficerSSale−1.52K$17.24−$26.2K−0.7%207.7K after
Jul 11, 2025 (view filing)Jul 92 daysGeffner MichaelChief Medical OfficerSSale−1.16K$17.24−$20.0K−0.5%224.2K after
Jul 25, 2025 (view filing)Jul 232 daysGeffner MichaelChief Medical OfficerSSale−2.38K$18.15−$43.3K−1.1%221.8K after
Jul 25, 2025 (view filing)Jul 232 daysStout Jay SChief Technology OfficerSSale−2.81K$18.15−$50.9K−1.4%204.9K after